Hims & Hers Health Inc (NYSE: HIMS) on Monday, plunged -2.35% from the previous trading day, before settling in for the closing price of $45.46. Within the past 52 weeks, HIMS’s price has moved between $18.70 and $72.98.
Healthcare Sector giant saw their annual sales surged by 17.22% over the last five years. The company achieved an average annual earnings per share of 2.91%. With a float of $203.00 million, this company’s outstanding shares have now reached $217.38 million.
Hims & Hers Health Inc (HIMS) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Hims & Hers Health Inc is 10.19%, while institutional ownership is 77.90%. The most recent insider transaction that took place on Oct 27 ’25, was worth 132,114. In this transaction Chief Legal Officer of this company sold 2,637 shares at a rate of $50.10, taking the stock ownership to the 158,493 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Officer proposed sale 2,637 for $50.10, making the entire transaction worth $132,114.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.11 earnings per share (EPS) for the period topping the consensus outlook (set at 0.11) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.86% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Hims & Hers Health Inc (HIMS) is currently performing well based on its current performance indicators. A quick ratio of 4.46 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.98. Likewise, its price to free cash flow for the trailing twelve months is 86.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.80, a number that is poised to hit 0.10 in the next quarter and is forecasted to reach 0.76 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Analysing the last 5-days average volume posted by the [Hims & Hers Health Inc, HIMS], we can find that recorded value of 22.62 million was lower than the volume posted last year of 32.37 million. As of the previous 9 days, the stock’s Stochastic %D was 8.28%.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 12.18%, which indicates a significant increase from 1.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.59 in the past 14 days, which was higher than the 3.53 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.41, while its 200-day Moving Average is $46.48. Now, the first resistance to watch is $46.36. This is followed by the second major resistance level at $48.32. The third major resistance level sits at $49.50. If the price goes on to break the first support level at $43.22, it is likely to go to the next support level at $42.04. Should the price break the second support level, the third support level stands at $40.08.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
Market capitalization of the company is 10.03 billion based on 226,020K outstanding shares. Right now, sales total 1,477 M and income totals 126,040 K. The company made 544,830 K in profit during its latest quarter, and 42,510 K in sales during its previous quarter.
